Key Developments For Strategic Diagnostics Inc.
Strategic Diagnostics Inc. (SDIX.O) (Consolidated Issue listed on NASDAQ Global Market)
Strategic Diagnostics Inc. and DuPont Qualicon Expand Global Distribution Agreement
Strategic Diagnostics Inc. (SDI) and DuPont Qualicon announced the expansion of their distribution agreement to include SDI's RapidChek SELECT products. Under the terms of the expanded agreement, DuPont Qualicon will now also market SDI's RapidChek SELECT tests and enrichment media under the same name. SDI will continue to market its RapidChek and RapidChek SELECT line of food pathogen test systems directly in the United States and through selected distributors outside the U.S.
Strategic Diagnostics Inc. Awarded Patent For Use Of Bacteriophages In Microbiological Assays and Processes
Strategic Diagnostics Inc. announced that it has been awarded U.S. Patent No. 7,521,201 B2 for using bacteriophages in microbiological assay tests and processes.
Strategic Diagnostics Inc. Appoints Kevin J. Bratton As Chief Financial Officer
Strategic Diagnostics Inc. announced that Kevin J. Bratton has joined the Company as its Vice President of Finance and Chief Financial Officer, effective June 1, 2009.
Strategic Diagnostics Inc. Issues Q4 2008 Guidance
Strategic Diagnostics Inc. announced that for fourth quarter of 2008, it expects increase in revenues of approximately 2% and an improvement of approximately $600,000 in income from ongoing operations when compared to the third quarter of 2008.
Strategic Diagnostics Inc. Announces Stanley Fronczkowski to Step Down as Chief Financial Officer
Strategic Diagnostics Inc. announced that Stanley Fronczkowski, Chief Financial Officer (CFO), will be stepping down from his current position to pursue other interests, effective April 3, 2009. Mr. Fronczkowski will remain as CFO until that date.
